ASSESSING TREATMENT PATTERNS WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AND PREDNISONE FOR PSORIATIC ARTHRITIS BY RACE/ETHNICITY

被引：0
|
作者：
Ahmed, F. [1 ]
Ogdie, A. [2 ]
Fitzsimmons, R. [1 ]
Shin, D. [1 ]
Takeshita, J. [1 ]
机构：
[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Rheumatol, Philadelphia, PA 19104 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2483
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1049
引用
收藏
页码：843 / 843
页数：1
相关论文
共 50 条
  • [1] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis
    Marguerie, L
    Flipo, RM
    Grardel, B
    Beaurain, D
    Duquesnoy, B
    Delcambre, B
    JOINT BONE SPINE, 2002, 69 (03) : 275 - 281
  • [2] Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review
    Kingsley, Gabrielle H.
    Scott, David L.
    PSORIASIS-TARGETS AND THERAPY, 2015, 5 : 71 - 81
  • [3] Predictors of effectiveness of biologic disease-modifying antirheumatic drugs (bDMARD) in the treatment of psoriatic arthritis
    Brandao, Natalia Dias
    Morgado, Marina
    Oliveira, Gerusa A.
    Acurcio, Francisco de Assis
    Guerra Junior, Augusto Afonso
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 170 - 171
  • [4] Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
    Huabin F Zhang
    Geneviève Gauthier
    Robert Hiscock
    Jeffrey R Curtis
    Arthritis Research & Therapy, 16
  • [5] Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
    Zhang, Huabin F.
    Gauthier, Genevieve
    Hiscock, Robert
    Curtis, Jeffrey R.
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (04)
  • [6] Treatment Patterns with Disease-Modifying Antirheumatic Drugs in US Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Walsh, Jessica A.
    Pei, Shaobo
    Penmetsa, Gopi K.
    Sauer, Brian C.
    Patil, Vikas
    Walker, Jodi H.
    Clewell, Jerry
    Douglas, Kevin M.
    Clegg, Daniel O.
    Cannon, Grant W.
    Halwani, Ahmad
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1218 - +
  • [7] Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review
    Maese, Jesus
    Diaz del Campo, Petra
    Seoane-Mato, Daniel
    Guerra, Mercedes
    Canete, Juan D.
    REUMATOLOGIA CLINICA, 2018, 14 (02): : 81 - 89
  • [8] An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis
    So, Anthony
    Inman, Robert Davies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 453 - 471
  • [9] Combination of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis
    Ribeiro, Andre Lucas
    Abarza, Virginia Carrizo
    Gladman, Dafna
    Chandran, Vinod
    Eder, Lihi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4728 - 4730
  • [10] The Actual Role of Therapy with Traditional Disease-modifying Antirheumatic Drugs in Psoriatic Arthritis
    Soriano, Enrique R.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 : 67 - 70
12345